Methylprednisolone succinate

From Wikipedia, the free encyclopedia
  (Redirected from Solu-Medrol)
Jump to navigation Jump to search
Methylprednisolone succinate
Methylprednisolone sodium succinate.svg
Clinical data
Trade namesSolu-Medrol, Solu-Medrone, Urbason, others
Other namesMethylprednisolone hemisuccinate; 6α-Methylprednisolone 21-hemisuccinate
Routes of
administration
Intravenous injection
Drug classCorticosteroid; Glucocorticoid
Identifiers
CAS Number
PubChem CID
DrugBank
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.017.416 Edit this at Wikidata
Chemical and physical data
FormulaC26H34O8
Molar mass474.550 g·mol−1
3D model (JSmol)

Methylprednisolone succinate, sold under the brand names Solu-Medrol among others, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester—specifically the C21 succinate ester of methylprednisolone—which is used by intravenous administration.[1][2] Methylprednisolone succinate is provided as two different salts when used as a pharmaceutical drug: a sodium salt (methylprednisolone sodium succinate; brand name Solu-Medrol, others) and a hydrogen salt (methylprednisolone hemisuccinate or methylprednisolone hydrogen succinate; brand name Urbason).[1][2]

See also[edit]

References[edit]

  1. ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 811–. ISBN 978-1-4757-2085-3.
  2. ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 675–. ISBN 978-3-88763-075-1.